These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 19673692)
21. Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells. Chang CS; Liu JF; Lin HJ; Lin CD; Tang CH; Lu DY; Sing YT; Chen LY; Kao MC; Kuo SC; Lai CH Eur J Med Chem; 2012 Feb; 48():244-54. PubMed ID: 22217866 [TBL] [Abstract][Full Text] [Related]
22. Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus. Liu JH; Li L; Shang XD; Zhang JL; Tan Q J Ethnopharmacol; 2016 May; 183():54-58. PubMed ID: 26364939 [TBL] [Abstract][Full Text] [Related]
23. Metronidazole-deoxybenzoin derivatives as anti-Helicobacter pylori agents with potent inhibitory activity against HPE-induced interleukin-8. Luo Y; Li HQ; Zhou Y; Li ZL; Yan T; Zhu HL ChemMedChem; 2010 Jul; 5(7):1110-6. PubMed ID: 20446277 [TBL] [Abstract][Full Text] [Related]
24. Structural modification of a specific antimicrobial lead against Helicobacter pylori discovered from traditional Chinese medicine and a structure-activity relationship study. Zhang BL; Fan CQ; Dong L; Wang FD; Yue JM Eur J Med Chem; 2010 Nov; 45(11):5258-64. PubMed ID: 20832915 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI Eur J Med Chem; 2006 Feb; 41(2):208-12. PubMed ID: 16377035 [TBL] [Abstract][Full Text] [Related]
26. Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. Klesiewicz K; Karczewska E; Budak A; Marona H; Szkaradek N J Antibiot (Tokyo); 2016 Nov; 69(11):825-834. PubMed ID: 27025351 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis: preliminary report. Boyanova L; Derejian S; Koumanova R; Katsarov N; Gergova G; Mitov I; Nikolov R; Krastev Z J Med Microbiol; 2003 May; 52(Pt 5):417-419. PubMed ID: 12721318 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and Structure-Activity Relationship of Palmatine Derivatives as a Novel Class of Antibacterial Agents against Fan T; Guo X; Zeng Q; Wei W; You X; Wang Y; Pang J; Song D Molecules; 2020 Mar; 25(6):. PubMed ID: 32188132 [TBL] [Abstract][Full Text] [Related]
29. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives. Spósito L; Oda FB; Vieira JH; Carvalho FA; Dos Santos Ramos MA; de Castro RC; Crevelin EJ; Crotti AEM; Santos AG; da Silva PB; Chorilli M; Bauab TM J Ethnopharmacol; 2019 Apr; 233():1-12. PubMed ID: 30594606 [TBL] [Abstract][Full Text] [Related]
30. Non-steroidal anti-inflammatory drugs have bacteriostatic and bactericidal activity against Helicobacter pylori. Shirin H; Moss SF; Kancherla S; Kancherla K; Holt PR; Weinstein IB; Sordillo EM J Gastroenterol Hepatol; 2006 Sep; 21(9):1388-93. PubMed ID: 16911681 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of New Nitrofluoroquinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant H. pylori. Abu-Qatouseh L; Abu-Sini M; Mayyas A; Al-Hiari Y; Darwish R; Aburjai T Molecules; 2017 Jan; 22(1):. PubMed ID: 28054994 [TBL] [Abstract][Full Text] [Related]
32. [In vitro antibacterial activity of Chilean propolis against Helicobacter pylori]. Villanueva M; González M; Fernández H; Wilson M; Manquián N; Otth C; Otth L Rev Chilena Infectol; 2015 Oct; 32(5):530-5. PubMed ID: 26633110 [TBL] [Abstract][Full Text] [Related]
33. Arylamino containing hydroxamic acids as potent urease inhibitors for the treatment of Helicobacter pylori infection. Liu Q; Shi WK; Ren SZ; Ni WW; Li WY; Chen HM; Liu P; Yuan J; He XS; Liu JJ; Cao P; Yang PZ; Xiao ZP; Zhu HL Eur J Med Chem; 2018 Aug; 156():126-136. PubMed ID: 30006158 [TBL] [Abstract][Full Text] [Related]
34. Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles. Katsura Y; Nishino S; Tomishi T; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H Bioorg Med Chem Lett; 1998 Jun; 8(11):1307-12. PubMed ID: 9871756 [TBL] [Abstract][Full Text] [Related]
35. Discovery of a novel benzyloxyisoquinoline derivative with potent anti-Helicobacter pylori activity. Yoshida Y; Barrett D; Azami H; Morinaga C; Matsumoto Y; Takasugi H Bioorg Med Chem Lett; 1998 Jul; 8(14):1897-902. PubMed ID: 9873455 [TBL] [Abstract][Full Text] [Related]
36. Discovery of Cinnamic Acid Derivatives as Potent Anti- Li Y; Zhao K; Wu Z; Zheng Y; Yu J; Wu S; Wong VKW; Chen M; Liu W; Zhao S Molecules; 2024 Sep; 29(19):. PubMed ID: 39407478 [TBL] [Abstract][Full Text] [Related]
38. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori. Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711 [TBL] [Abstract][Full Text] [Related]